ADMA Biologics, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2025: 12.55

ADMA Biologics, Inc. Interest Coverage Ratio is 12.55 for the Trailing 12 Months (TTM) ending March 31, 2025, a 1,376.64% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.
  • ADMA Biologics, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2024 was 0.85, a -172.86% change year over year.
  • ADMA Biologics, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2023 was -1.17, a -76.22% change year over year.
  • ADMA Biologics, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2022 was -4.91, a -2.01% change year over year.
  • ADMA Biologics, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2021 was -5.01, a 15.01% change year over year.
Key Data
Date Interest Coverage Ratio Return on Capital Employed (ROCE) Return on Equity (ROE) Return on Assets (ROA)